- Home
- GMED
GMED
Globus Medical Inc.
as 07-26-2024 4:00pm EST
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.
| Founded: | 2003 | Country: | United States |
| Employees: | N/A | City: | AUDUBON |
| Market Cap: | 9.7B | IPO Year: | 2012 |
| Target Price: | $71.50 | AVG Volume (30 days): | 810.0K |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.62 | EPS Growth: | -68.53 |
| 52 Week Low/High: | $43.39 - $74.16 | Next Earning Date: | 08-06-2024 |
| Revenue: | $1,898,454,000 | Revenue Growth: | 77.59% |
| Revenue Growth (this year): | 60.92% | Revenue Growth (next year): | 7.25% |
Stock Insider Trading Activity of Globus Medical Inc. (GMED)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Norwalk Leslie V | GMED | Director | Jul 11 '24 | Sell | $70.00 | 1,000 | $70,000.00 | 16,419 | SEC Form 4 |
| Lemaitre Dan | GMED | Director | May 10 '24 | Sell | $64.61 | 63,300 | $4,090,021.89 | 0 | SEC Form 4 |
| Davidar David D | GMED | Director | May 8 '24 | Sell | $65.00 | 20,000 | $1,300,000.00 | 566,275 | SEC Form 4 |
| Norwalk Leslie V | GMED | Director | Mar 15 '24 | Sell | $51.99 | 10,590 | $550,574.10 | 17,419 | SEC Form 4 |
| Huller Kelly | GMED | SVP, GC, Corporate Secretary | Mar 1 '24 | Sell | $53.79 | 4,385 | $235,869.15 | 3,115 | SEC Form 4 |
| Huller Kelly | GMED | SVP, GC, Corporate Secretary | Mar 1 '24 | Sell | $54.53 | 3,115 | $169,860.95 | 0 | SEC Form 4 |
Latest Globus Medical Inc. News
GMED Breaking Stock News: Dive into GMED Ticker-Specific Updates for Smart Investing
Zacks
7 hours ago
3 Reasons Why You Should Hold HealthEquity (HQY) Stock Now
Zacks
2 days ago
Boston Scientific (BSX) Q2 Earnings Beat, Organic Sales Rise
Zacks
2 days ago
Veeva Systems' (VEEV) Vault EDC to Boost Vita Global's Workflow
Zacks
2 days ago
Thermo Fisher (TMO) Beats on Q2 Earnings, Raises 2024 EPS View
Zacks
3 days ago
Quest Diagnostics' (DGX) Haystack Oncology Forges New MRD Deal
Argus Research
3 days ago
GMED: Rating increased to a HOLD
Zacks
4 days ago
Inspire Medical's (INSP) Inspire Therapy Gets CE Mark Approval
Zacks
7 days ago
Globus Medical (GMED) Global Sales, Innovation Aid Growth
Compare GMED vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GMED Globus Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.